310 companies
Cultivo Land PBC
California
CYDY
CytoDyn Inc.
We are focused on developing leronlimab, a monoclonal antibody C - C chemokine receptor type 5 (“CCR5”) receptor antagonist, to be used as a platform drug for a variety of indications. The target of leronlimab is the immunologic receptor CCR5. The CCR5 receptor is a protein located on the surface of a variety of cells including white blood cells and cancer cells.
Washington
OTC
DMG Buffalo Student Income Feeder LP
California
DMG Buffalo Student Income Master LP
California
Daksob LLC
Delaware
Darrell Schmidt Enterprises Inc
Texas
Deloitte & Touche LLP
New York
Deloitte Consulting LLP
New York
Deloitte Financial Advisory Services LLP
New York
Deloitte LLP
New York
Deloitte Tax LLP
New York
Deloitte Touche Tohmatsu Services, Inc.
New York
Deutsche DWS Money Market Trust
New York
Deutsche DWS Municipal Trust
New York
Deutsche DWS Tax Free Trust
New York
Dixon Hughes Goodman Wealth Advisors LLC
Dos Mil Doscientos Uno, S.L.
Spain
Drake Petroleum Company, Inc.
Massachusetts
Dreyfus Intermediate Municipal Bond Fund Inc
New York
Dreyfus New York Tax Exempt Bond Fund Inc
New York